EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced suppression of Stenotrophomonas maltophilia by a three-phage cocktail: genomic insights and kinetic profiling

Alisha N Monsibais iD, Olivia Tea, Pooja Ghatbale, Sage J B Dunham iD, Mirjam Zünd iD, Jennifer Phan, Karen Lam, McKenna Paulson, Natalie Tran, Diana S Suder iD, Alisha N Blanc, Cyril Samillano und 8 weitere

Antimicrobial Agents and Chemotherapy · 05.03.2025 · 69 (3)

DOI: 10.1128/aac.01162-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.03.2025. Verfasst von Alisha N Monsibais und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, California, USA. Hauptthemen laut MEDLINE: Stenotrophomonas maltophilia, Bacteriophages, Phage Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Research (CFRI), Cystic Fibrosis Foundation (CFF), NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stenotrophomonas maltophilia is an understudied, gram-negative, aerobic bacterium that is widespread in the environment and increasingly a cause of opportunistic infections. Treating S. maltophilia remains difficult, leading to an increase in disease severity and higher hospitalization rates in people with cystic fibrosis, cancer, and other immunocompromised health conditions. The lack of effective antibiotics has led to renewed interest in phage therapy; however, there remains a great need for well-characterized phages, especially against S. maltophilia . In response to an oncology patient with a sepsis infection, we collected 18 phages from Southern California wastewater influent that exhibit different plaque morphology against S. maltophilia host strain B28B. We hypothesized that, when combined into a cocktail, genetically diverse phages would give rise to distinct lytic infection kinetics that would enhance bacterial killing when compared to the individual phages alone. We identified three genetically distinct clusters of phages, and a representative from each group was further investigated and screened for potential therapeutic use. The results demonstrated that the three-phage cocktail significantly suppressed bacterial growth compared with individual phages when observed for 48 h. We also assessed the lytic impacts of our three-phage cocktail against a collection of 46 S . maltophilia strains to determine if a multi-phage cocktail has an expanded host range. Our phages remained strain-specific and infected >50% of tested strains. In six clinically relevant S. maltophilia strains, the multi-phage cocktail has enhanced suppression of bacterial growth. These findings suggest that specialized phage cocktails may be an effective avenue of treatment for recalcitrant S. maltophilia infections resistant to current antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stenotrophomonas maltophiliaBacteriophagesPhage TherapyHumansGram-Negative Bacterial InfectionsKineticsAnti-Bacterial AgentsWastewaterGenomics

Stichwörter der Autor:innen

Stenotrophomonas maltophiliaantimicrobial resistancebacteriophagesgenomics

Substanzen

Anti-Bacterial AgentsWastewater

Autor:innen und Institutionen

  • Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, California, USA.
  • Department of Pathology, University of California San Diego, La Jolla, California, USA.
  • Department of Medicine, University of California San Diego, La Jolla, California, USA.

ORCID-Profile: Alisha N Monsibais, Sage J B Dunham, Mirjam Zünd, Diana S Suder, Hanna Atif, Ethan Vien, Ryan Nguyen, Allene Vo, Shane Gonen, David Pride, Katrine Whiteson

Förderung

  • Cystic Fibrosis Research (CFRI)
  • Cystic Fibrosis Foundation (CFF)
  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • National Science Foundation (NSF)
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • Swiss National Science Foundation - PostDoc.Mobility
  • NIGMS NIH HHS

Zitieren

APA

Monsibais, A. N., Tea, O., Ghatbale, P., Dunham, S. J. B., Zünd, M., Phan, J., Lam, K., Paulson, M., Tran, N., Suder, D. S., Blanc, A. N., Samillano, C., Suh, J., Atif, H., Vien, E., Nguyen, R., Vo, A., Gonen, S., Pride, D., & Whiteson, K. (2025). Enhanced suppression of Stenotrophomonas maltophilia by a three-phage cocktail: genomic insights and kinetic profiling. Antimicrobial Agents and Chemotherapy, 69(3). https://doi.org/10.1128/aac.01162-24

Vancouver

Monsibais AN, Tea O, Ghatbale P, Dunham SJB, Zünd M, Phan J, et al. Enhanced suppression of Stenotrophomonas maltophilia by a three-phage cocktail: genomic insights and kinetic profiling. Antimicrobial Agents and Chemotherapy. 2025;69(3). doi:10.1128/aac.01162-24

BibTeX
@article{Monsibais2025,
  author = {Monsibais, Alisha N and Tea, Olivia and Ghatbale, Pooja and Dunham, Sage J B and Zünd, Mirjam and Phan, Jennifer and Lam, Karen and Paulson, McKenna and Tran, Natalie and Suder, Diana S and Blanc, Alisha N and Samillano, Cyril and Suh, Joy and Atif, Hanna and Vien, Ethan and Nguyen, Ryan and Vo, Allene and Gonen, Shane and Pride, David and Whiteson, Katrine},
  title = {Enhanced suppression of Stenotrophomonas maltophilia by a three-phage cocktail: genomic insights and kinetic profiling},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  volume = {69},
  number = {3},
  doi = {10.1128/aac.01162-24}
}
Kostenlos starten →